Asmodium falciparum identification and tracking. Malar J 2008, 7:223. Trager W, Jensen JB: Human malaria parasites in continuous culture. Science 1976, 193:67375. Plouffe D, Brinker A, McNamara C, Henson K, Kato N, Kuhen K, Nagle A, Adrian F, Matzen JT, Anderson P, Nam TG, Gray NS, Chatterjee A, Janes J, Yan SF, Trager R, Caldwell JS, Schultz PG, Zhou Y, Winzeler EA: In silico activity profiling reveals the mechanism of action of antimalarials found in a high-throughput screen. Proc Natl Acad Sci U S A 2008, 105:9059064. Zhang JH, Chung TD, Oldenburg KR: A basic statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999, 4:673.Van Tyne et al. Malaria Journal 2013, 12:441 http://www.malariajournal/content/12/1/Page ten of25. Mita T, Kaneko A, Lum JK, Bwijo B, Takechi M, Zungu IL, Tsukahara T, Tanabe K, Kobayakawa T, Bjorkman A: Recovery of chloroquine sensitivity and low prevalence from the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg 2003, 68:41315. 26. Sa JM, Twu O, Hayton K, Reyes S, Fay MP, Ringwald P, Wellems TE: Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc Natl Acad Sci U S A 2009, 106:188838889. 27. Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Cost RN, Ringwald P: A systematic critique and meta-analysis of evidence for correlation involving molecular markers of parasite resistance and therapy outcome in falciparum malaria. Malar J 2009, 8:89. 28. Happi CT, Gbotosho GO, Folarin OA, Bolaji OM, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM: Association involving mutations in Plasmodium falciparum chloroquine resistance transporter and P.S1p receptor agonist 1 falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P.Emodepside falciparum malaria-infected kids in Nigeria. Am J Trop Med Hyg 2006, 75:15561. 29. Pascual A, Parola P, Benoit-Vical F, Simon F, Malvy D, Picot S, Delaunay P, Basset D, Maubon D, Faugere B, Menard G, Bourgeois N, Oeuvray C, Didillon E, Rogier C, Pradines B: Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with standard ACT drugs against isolates of Plasmodium falciparum. Malar J 2012, 11:45. 30. Dokomajilar C, Nsobya SL, Greenhouse B, Rosenthal PJ, Dorsey G: Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an location of Uganda exactly where malaria is very endemic. Antimicrob Agents Chemother 2006, 50:1893895. 31. Gadalla NB, Adam I, Elzaki SE, Bashir S, Mukhtar I, Oguike M, Gadalla A, Mansour F, Warhurst D, El-Sayed BB, Sutherland CJ: Improved pfmdr1 copy quantity and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria individuals treated with artemether-lumefantrine.PMID:24013184 Antimicrob Agents Chemother 2011, 55:5408411. 32. Wurtz N, Fall B, Pascual A, Diawara S, Sow K, Baret E, Diatta B, Fall KB, Mbaye PS, Fall F, Dieme Y, Rogier C, Bercion R, Briolant S, Wade B, Pradines B: Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal. Malar J 2012, 11:197. 33. Fall B, Pascual A, Sarr FD, Wurtz N, Richard V, Baret E, Dieme Y, Briolant S, Bercion R, Wade B, Tall A, Pradines B: Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study. Malar J two.
Related Posts
Tor cocktail showed a 3.3-fold increase in the proportion of blastocyst-stage-embryos.
Tor cocktail showed a 3.3-fold increase in the proportion of blastocyst-stage-embryos. The ability of these paracrine/ autocrine factors to promote development of early human embryos is consistent with findings showing zygote genome activation in human embryos at 4- to 8-cell stages on day 3 after fertilization when the expression of these growth factors begun to […]
S have been made.
ORIGINAL RESEARCHInsight and Treatment Outcomes in Schizophrenia: Post-hoc S had been created. ORIGINAL RESEARCHInsight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XRABSTRACTABSTRACT: Objective: The objective of this post-hoc analysis was to evaluate the effect of lurasidone and quetiapine extended-release (XR) on insight and judgment and assess […]
Ne interface (Fig. 1). Plain CT scanning was performed about every single 2 minNe interface
Ne interface (Fig. 1). Plain CT scanning was performed about every single 2 minNe interface (Fig. 1). Plain CT scanning was performed around just about every 2 min all through the freezing portions on the cycle to monitor the growth of the ice ball (Fig. 2). Each lesion was subject to three freezethawfreeze cycles, 20 […]